Liu, C., Schönke, M., Spoorenberg, B., Lambooij, J. M., van der Zande, H. J. P., Zhou, E., . . . Rensen, P. C. N. (2023). FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis. eLife, 1-24. https://doi.org/10.7554/eLife.83075
Chicago Style (17th ed.) CitationLiu, Cong, et al. "FGF21 Protects Against Hepatic Lipotoxicity and Macrophage Activation to Attenuate Fibrogenesis in Nonalcoholic Steatohepatitis." ELife 2023: 1-24. https://doi.org/10.7554/eLife.83075.
MLA (8th ed.) CitationLiu, Cong, et al. "FGF21 Protects Against Hepatic Lipotoxicity and Macrophage Activation to Attenuate Fibrogenesis in Nonalcoholic Steatohepatitis." ELife, 2023, pp. 1-24, https://doi.org/10.7554/eLife.83075.
Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.
Visit our Citation Styles guide for help on properly citing sources.